Ultra Market Research | Global Insomnia Market
Illuminate your understanding with Global Insomnia Market Insights. This captivating image depicts a world map overlaid with vibrant data visualizations and insightful graphs, symbolizing the comprehe

Global Insomnia Market

  • Report ID : 234

  • Category : Healthcare-Services,Global

  • No Of Pages : 200

  • Published on: April 2024

  • Status: Published

  • Format : Power Point PDF Excel Word

Key Question Answer

check-box

Global Market Outlook

check-box

In-depth analysis of global and regional trends

check-box

Analyze and identify the major players in the market, their market share, key developments, etc.

check-box

To understand the capability of the major players based on products offered, financials, and strategies.

check-box

Identify disrupting products, companies, and trends.

check-box

To identify opportunities in the market.

check-box

Analyze the regional penetration of players, products, and services in the market.

check-box

Comparison of major players financial performance.

check-box

Evaluate strategies adopted by major players.

check-box

Recommendations

Global Insomnia Market

 

Global insomnia market is defined as the market for pharmaceuticals, devices, and therapies aimed at diagnosing, treating, and managing insomnia, a common sleep disorder characterized by difficulty falling asleep, staying asleep, or both. The market size was estimated at USD 3.5 billion in 2023 and is forecasted to reach USD 5.6 billion by 2028, growing at a CAGR of 9.8% during the forecast period.

 

Market Overview
Insomnia affects a significant portion of the global population, with approximately 30% of adults experiencing symptoms of insomnia. The condition can have a profound impact on an individual's quality of life, leading to daytime fatigue, mood disturbances, and impaired cognitive function. As awareness about the adverse effects of insomnia grows, the demand for effective treatment options is also increasing, driving the growth of the insomnia market.

 

Market Dynamics
Drivers: Increasing prevalence of insomnia due to factors such as stress, lifestyle changes, and comorbidities like depression and anxiety.
Restraints: Limited efficacy and potential side effects of current treatment options, leading to patient dissatisfaction and non-adherence.
Challenges: Lack of definitive diagnostic criteria for insomnia, leading to underdiagnosis and inadequate treatment.
Opportunities: Growing research and development activities aimed at developing novel and more effective treatments for insomnia.
 

Key Insights in Different Regions
US: The US is the largest market for insomnia treatment, driven by a large patient population and a high prevalence of insomnia.
Europe: Europe is experiencing steady growth in the insomnia market, fueled by increasing awareness and improving healthcare infrastructure.
Japan: Japan has a mature market for insomnia treatment, with a focus on innovative therapies and personalized medicine.
China: China is witnessing rapid growth in the insomnia market, driven by urbanization, lifestyle changes, and increasing healthcare spending.
India: India is an emerging market for insomnia treatment, with a growing middle class and increasing awareness about sleep disorders.
 

 

Regional Status
US currently dominates the global insomnia market, accounting for the largest share of revenue. However, emerging markets like China and India are expected to witness the fastest growth due to changing demographics and increasing healthcare investments.

 

Market Segmentations & Fastest Growing Segmentation
Insomnia market can be segmented based on type of therapy (pharmacological and non-pharmacological), type of insomnia (acute and chronic), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies). The non-pharmacological therapy segment is expected to be the fastest-growing segment, driven by increasing demand for alternative treatments such as cognitive behavioral therapy for insomnia (CBT-I).

 

Major Companies Operating in Different Regions
Some of the major companies operating in the global insomnia market include Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Vanda Pharmaceuticals Inc. These companies are focusing on strategic initiatives such as mergers, acquisitions, and product launches to strengthen their market presence.

 

Latest News & Recent Development News
Merger: In 2023, Sanofi S.A. announced the acquisition of a leading insomnia treatment company, expanding its portfolio of sleep disorder therapies.
Product Launch: Pfizer Inc. launched a new insomnia medication with a novel mechanism of action, offering new treatment options for patients.
 

Market Segmentation in Proper Form
By Therapy: Pharmacological Therapy, Non-pharmacological Therapy
By Type of Insomnia: Acute Insomnia, Chronic Insomnia
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
 

Report Highlights
Increasing prevalence of insomnia driving market growth
Non-pharmacological therapies witnessing rapid adoption
US leading the global insomnia market, while China and India are emerging as key growth markets
 

Most Frequently Asked Questions Related to Market 

The current market size of the global insomnia market is valued at USD 2.79 billion in 2023 and is projected to grow at a CAGR of 4.4% from 2024 to 2030.
Key factors driving the growth of the insomnia market include the rising incidence of insomnia, increased awareness of sleep disorders, and the development of effective and safer treatment options.
The region that dominates the global insomnia market is North America, accounting for approximately 35.4% of the market share in 2023, driven by high healthcare spending and awareness initiatives.
Major companies operating in the insomnia market include Pfizer, Merck & Co., Sanofi, Takeda Pharmaceutical Company, and Ebb Therapeutics.
Latest developments in the insomnia market include the approval of new treatments like Quviviq by Indorsia, advancements in cognitive behavioral therapy (CBT), and increasing product launches in over-the-counter sleep aids.

Choose License Type

  • $3999

  • $5550

  • $6999

Our Reports Look Like This

Ultra Market Research

HAVE A QUESTION

will help you find what you are looking for:


Related Reports

Recent Reports

Subscribe to Newsletter

Provide your email to get email notification when we publish new reports.

whatsapp